Company page

Context Therapeutics Inc.

Context Therapeutics Inc. is a public company traded under the ticker CNTX in the American market. The company has a market capitalization of approximately $58 million. Context Therapeutics focuses on developing innovative therapies for women's cancers.

profileCNTX:NASDAQAI content: aiUpdated June 24, 2026/company/context-therapeutics-inc/c-8quzcaan
Context Therapeutics Inc. logo
Ticker
CNTX:NASDAQ
Asset type
Stock
Market cap
$58.1M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD